688278 特宝生物
已收盘 10-23 15:00:00
资讯
新帖
简况
股市必读：特宝生物新发布《特宝生物：2026年第三季度报告》
证券之星 · 05:28
股市必读：特宝生物新发布《特宝生物：2026年第三季度报告》
特宝生物最新公告：前三季度净利润同比下降28.34%
证券之星 · 10-22 19:29
特宝生物最新公告：前三季度净利润同比下降28.34%
特宝生物（688278）10月16日主力资金净卖出363.44万元
证券之星 · 10-17
特宝生物（688278）10月16日主力资金净卖出363.44万元
股市必读：特宝生物（688278）10月14日董秘有最新回复
证券之星 · 10-15
股市必读：特宝生物（688278）10月14日董秘有最新回复
特宝生物：公司中长期借款主要用于满足募投项目以外的基建项目建设和股份回购等中长期资金需求
证券之星 · 10-14
特宝生物：公司中长期借款主要用于满足募投项目以外的基建项目建设和股份回购等中长期资金需求
特宝生物：2025年转固的项目和本次可转债产线建设项目为两个独立项目
证券之星 · 10-14
特宝生物：2025年转固的项目和本次可转债产线建设项目为两个独立项目
特宝生物：保障产能与市场需求相匹配
证券之星 · 10-14
特宝生物：保障产能与市场需求相匹配
股市必读：特宝生物新发布《特宝生物：关于可转债投资者适当性要求的风险提示性公告》
证券之星 · 10-14
股市必读：特宝生物新发布《特宝生物：关于可转债投资者适当性要求的风险提示性公告》
股市必读：特宝生物新发布《特宝生物：关于股份回购进展公告》
证券之星 · 10-12
股市必读：特宝生物新发布《特宝生物：关于股份回购进展公告》
特宝生物（688278）披露股份回购进展公告，10月08日股价下跌3.95%
证券之星 · 10-08
特宝生物（688278）披露股份回购进展公告，10月08日股价下跌3.95%
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案获临时股东会审议通过，9月29日股价下跌0.78%
证券之星 · 09-29
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案获临时股东会审议通过，9月29日股价下跌0.78%
股市必读：特宝生物新发布《特宝生物：2026年第四次临时股东会法律意见书》
证券之星 · 09-29
股市必读：特宝生物新发布《特宝生物：2026年第四次临时股东会法律意见书》
【机构调研记录】博时基金调研特宝生物
证券之星 · 09-24
【机构调研记录】博时基金调研特宝生物
股市必读：特宝生物（688278）9月23日披露最新机构调研信息
证券之星 · 09-24
股市必读：特宝生物（688278）9月23日披露最新机构调研信息
特宝生物：中金公司、红杉资本等多家机构于9月22日调研我司
证券之星 · 09-24
特宝生物：中金公司、红杉资本等多家机构于9月22日调研我司
每周股票复盘：特宝生物（688278）CT201明年或有数据读出
证券之星 · 09-20
每周股票复盘：特宝生物（688278）CT201明年或有数据读出
股市必读：特宝生物新发布《特宝生物：关于召开2026年第四次临时股东会的通知》
证券之星 · 09-14
股市必读：特宝生物新发布《特宝生物：关于召开2026年第四次临时股东会的通知》
每周股票复盘：特宝生物（688278）将召开临时股东会审议关联交易
证券之星 · 09-13
每周股票复盘：特宝生物（688278）将召开临时股东会审议关联交易
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案，9月11日股价下跌4.51%
证券之星 · 09-11
特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案，9月11日股价下跌4.51%
特宝生物（688278）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价下跌0.91%
证券之星 · 09-08
特宝生物（688278）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价下跌0.91%
加载更多
公司概况
公司名称：
厦门特宝生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2020-01-17
主营业务：
厦门特宝生物工程股份有限公司的主营业务是免疫和代谢领域创新药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康。派格宾于2025年10月获批成为全球首个以慢乙肝临床治愈为治疗终点的药物，是该领域重要基石药物。
发行价格：
8.24
{"stockData":{"symbol":"688278","market":"SH","secType":"STK","nameCN":"特宝生物","latestPrice":43.77,"timestamp":1792738800000,"preClose":45.17,"halted":0,"volume":4356189,"delay":0,"changeRate":-0.031,"floatShares":408000000,"shares":408000000,"eps":2.064,"marketStatus":"已收盘","change":-1.4,"latestTime":"10-23 15:00:00","open":41.15,"high":43.87,"low":41.11,"amount":186000000,"amplitude":0.0611,"askPrice":43.77,"askSize":3,"bidPrice":43.75,"bidSize":67,"shortable":0,"etf":0,"ttmEps":2.064,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"adjPreClose":45.17,"symbolType":"stock_kcb","openAndCloseTimeList":[[1792719000000,1792726200000],[1792731600000,1792738800000]],"highLimit":49.69,"lowLimit":40.65,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":408189480,"isCdr":false,"pbRate":5.74,"roa":"--","peRate":21.206395,"roe":"14.22%","epsLYR":2.53,"committee":-0.040964,"marketValue":17866000000,"turnoverRate":0.0107,"status":1,"afterMarket":{"amount":42106.74,"volume":962,"close":43.77,"buyVolume":0,"sellVolume":1738,"time":1792740837746,"indexStatus":"已收盘 10-23 15:30:00","preClose":45.17},"floatMarketCap":17866000000},"requestUrl":"/m/hq/s/688278","defaultTab":"news","newsList":[{"id":"2677875992","title":"股市必读：特宝生物新发布《特宝生物：2026年第三季度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677875992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677875992?lang=zh_cn&edition=full","pubTime":"2026-10-23 05:28","pubTimestamp":1792704495,"startTime":"0","endTime":"0","summary":"公司公告汇总：实际控制人杨英、孙黎及一致行动人蔡智华承诺自10月22日起5年内不减持合计44.61%股份。公司公告汇总特宝生物：2026年第三季度报告2026年第三季度营业收入895,810,778.30元，同比下降7.55%；归属于上市公司股东的净利润836,016.80元，同比下降99.65%。年初至报告期末营业收入2,732,374,422.43元，同比增长10.20%；归属于上市公司股东的净利润477,362,962.81元，同比下降28.34%。截至公告日，三人合计持有公司182,092,624股，占总股本的44.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677950565","title":"特宝生物最新公告：前三季度净利润同比下降28.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677950565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677950565?lang=zh_cn&edition=full","pubTime":"2026-10-22 19:29","pubTimestamp":1792668584,"startTime":"0","endTime":"0","summary":"特宝生物(688278.SH)公告称，第三季度营业收入为8.96亿元，同比下降7.55%；净利润为83.60万元，同比下降99.65%。前三季度营业收入为27.32亿元，同比增长10.20%；净利润为4.77亿元，同比下降28.34%。业绩变动原因：本报告期支付慢乙肝管线ACT580、ACT201BD相关一次性费用，故研发费用大幅增加。此外，报告期内，普通生物制品增值税税率由简易征收率3%调整为一般计税13%，对营业收入有所影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200036759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676510125","title":"特宝生物（688278）10月16日主力资金净卖出363.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676510125","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676510125?lang=zh_cn&edition=full","pubTime":"2026-10-17 08:27","pubTimestamp":1792196855,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月16日收盘，特宝生物报收于47.0元，下跌1.94%，换手率0.68%，成交量2.77万手，成交额1.33亿元。10月16日的资金流向数据方面，主力资金净流出363.44万元，占总成交额2.74%，游资资金净流出339.76万元，占总成交额2.56%，散户资金净流入703.2万元，占总成交额5.31%。融券方面，融券卖出700.0股，融券偿还800.0股，融券余量11.93万股，融券余额560.7万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101700005917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675329923","title":"股市必读：特宝生物（688278）10月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675329923","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675329923?lang=zh_cn&edition=full","pubTime":"2026-10-15 01:30","pubTimestamp":1791999033,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，特宝生物报收于46.43元，下跌3.25%，换手率0.65%，成交量2.66万手，成交额1.24亿元。董秘最新回复投资者： 根据26年7月东方金诚的评级报告中显示:派格宾的产能利用率持续超100%。综上，2025年转固的项目和本次可转债产线建设项目为两个独立项目。当日关注点交易信息汇总：10月14日主力资金净流出941.58万元，占总成交额7.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675319763","title":"特宝生物：公司中长期借款主要用于满足募投项目以外的基建项目建设和股份回购等中长期资金需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2675319763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675319763?lang=zh_cn&edition=full","pubTime":"2026-10-14 15:34","pubTimestamp":1791963255,"startTime":"0","endTime":"0","summary":"证券之星消息，特宝生物10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司可转债募集资金15亿左右，加上公司已有的账面资金和现金流，完全可以覆盖3大项目的总体开支。公司中长期借款主要用于满足募投项目以外的基建项目建设和股份回购等中长期资金需求，未来将结合项目资金需求和整体融资成本，统筹安排借款的取得与偿还。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400020964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675319037","title":"特宝生物：2025年转固的项目和本次可转债产线建设项目为两个独立项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2675319037","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675319037?lang=zh_cn&edition=full","pubTime":"2026-10-14 15:34","pubTimestamp":1791963255,"startTime":"0","endTime":"0","summary":"请问:25年转固的该项目和本次可转债对应的益佩生扩产项目有什么关系？本次可转债“特宝生物创新药物生产改扩项目-产线建设”募投项目主要为产线建设，包含机器设备及相关产线投入，是为响应中长期市场需求、提升公司智能化生产水平开展的项目，项目建成后将提升益佩生的规模化生产能力，满足生长激素缺乏相关疾病治疗领域持续增长的市场需求。综上，2025年转固的项目和本次可转债产线建设项目为两个独立项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400020965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675131905","title":"特宝生物：保障产能与市场需求相匹配","url":"https://stock-news.laohu8.com/highlight/detail?id=2675131905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675131905?lang=zh_cn&edition=full","pubTime":"2026-10-14 15:34","pubTimestamp":1791963255,"startTime":"0","endTime":"0","summary":"证券之星消息，特宝生物(688278)10月14日在投资者关系平台上答复投资者关心的问题。投资者提问：根据26年7月东方金诚的评级报告中显示:派格宾的产能利用率持续超100%。请问:派格宾目前的产能情况、利用率以及公司对派格宾产能的预判和相关规划？谢谢特宝生物回复：您好！随着慢性乙肝临床治愈理念的普及和科学证据的积累，派格宾的市场需求持续增长，公司将密切跟踪市场需求变化，结合销售情况动态调整生产计划、科学统筹产线资源与生产安排，保障产能与市场需求相匹配。感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400020959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675642593","title":"股市必读：特宝生物新发布《特宝生物：关于可转债投资者适当性要求的风险提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675642593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675642593?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:41","pubTimestamp":1791920468,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，特宝生物报收于47.99元，下跌3.85%，换手率0.72%，成交量2.92万手，成交额1.42亿元。当日关注点交易信息汇总：10月13日主力资金净流出79.21万元，占总成交额0.56%。公司公告汇总：特宝生物发布可转债投资者适当性要求的风险提示性公告，明确“特宝转债”自2027年2月3日起可转股，参与转股须符合科创板投资者适当性管理要求。可转债已于2026年8月13日在上交所上市，债券代码118074。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400003662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674466708","title":"股市必读：特宝生物新发布《特宝生物：关于股份回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674466708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674466708?lang=zh_cn&edition=full","pubTime":"2026-10-12 03:43","pubTimestamp":1791747791,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总：10月9日主力资金净流出320.54万元，占总成交额3.03%； 公司公告汇总：截至2026年9月30日，特宝生物累计回购股份7,381,464股，占总股本1.81%，已支付资金总额4.065亿元，回购价格区间为52.62–57.20元/股，9月未实施回购。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055710","title":"特宝生物（688278）披露股份回购进展公告，10月08日股价下跌3.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673055710?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:39","pubTimestamp":1791470351,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，特宝生物报收于50.8元，较前一交易日下跌3.95%，最新总市值为207.36亿元。近日，特宝生物发布《关于股份回购进展公告》。公告显示，公司于2026年5月11日召开董事会，审议通过以集中竞价交易方式回购股份的方案，回购期限为2026年5月12日至2027年5月11日，拟回购金额为30,000万元至50,000万元，用于员工持股计划或股权激励及转换公司可转债。2026年9月未进行回购交易。回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800034752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671188142","title":"特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案获临时股东会审议通过，9月29日股价下跌0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671188142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671188142?lang=zh_cn&edition=full","pubTime":"2026-09-29 17:36","pubTimestamp":1790674576,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，特宝生物报收于51.2元，较前一交易日下跌0.78%，最新总市值为208.99亿元。该股当日开盘51.55元，最高52.2元，最低50.9元，成交额达9233.77万元，换手率为0.44%。近日，特宝生物发布《2026年第四次临时股东会决议公告》显示，公司于2026年9月28日召开2026年第四次临时股东会，审议通过《关于与关联人共同投资暨关联交易的议案》。出席股东所持表决权占公司总表决权的26.5543%，议案获普通决议通过，关联股东回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900029167.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252152","title":"股市必读：特宝生物新发布《特宝生物：2026年第四次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252152","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671252152?lang=zh_cn&edition=full","pubTime":"2026-09-29 02:38","pubTimestamp":1790620690,"startTime":"0","endTime":"0","summary":"公司公告汇总：特宝生物于2026年9月28日召开第四次临时股东会，审议通过《关于与关联人共同投资暨关联交易的议案》，中小投资者表决同意占比达99.72%。公司公告汇总特宝生物：2026年第四次临时股东会法律意见书厦门市锦天城（深圳）律师事务所出具法律意见书，确认厦门特宝生物工程股份有限公司2026年第四次临时股东会的召集、召开程序，召集人及出席人员资格，表决程序与表决结果均符合《公司法》《公司章程》等相关规定，会议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900002397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669661432","title":"【机构调研记录】博时基金调研特宝生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2669661432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669661432?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:01","pubTimestamp":1790208104,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月23日披露的机构调研信息，博时基金近期对1家上市公司进行了调研，相关名单如下：1）特宝生物 调研纪要：益佩生目前销售情况基本符合预期。研发费用与研发项目投入需求相关。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669493433","title":"股市必读：特宝生物（688278）9月23日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2669493433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669493433?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:30","pubTimestamp":1790188237,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，特宝生物报收于53.1元，上涨1.84%，换手率0.66%，成交量2.7万手，成交额1.43亿元。机构调研要点：公司乙肝管线CT201已进入I期临床并完成首例受试者给药；CT580国内II期临床正有序推进，并开展与派格宾的联合治疗探索。机构调研要点9月22日特定对象调研益佩生目前销售情况基本符合预期；该产品于2025年5月获批，2025年12月纳入国家医保目录，在疗效、安全性及使用便捷性方面具备差异化优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669438531","title":"特宝生物：中金公司、红杉资本等多家机构于9月22日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2669438531","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669438531?lang=zh_cn&edition=full","pubTime":"2026-09-24 01:05","pubTimestamp":1790183120,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月23日特宝生物发布公告称中金公司、红杉资本、中信建投、申万宏源、万家基金、幸福人寿、国盛证券、嘉实基金、安信基金、博时基金、太朴生命科学投资、德福资本、青榕资产、苏州云阳投资于2026年9月22日调研我司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400001885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668906218","title":"每周股票复盘：特宝生物（688278）CT201明年或有数据读出","url":"https://stock-news.laohu8.com/highlight/detail?id=2668906218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668906218?lang=zh_cn&edition=full","pubTime":"2026-09-20 01:26","pubTimestamp":1789838774,"startTime":"0","endTime":"0","summary":"截至2026年9月18日收盘，特宝生物报收于51.5元，较上周的52.05元下跌1.06%。本周，特宝生物9月14日盘中最高价报52.44元。本周关注点来自机构调研要点：CT201已进入I期临床并完成首例给药，公司希望明年有相关数据读出。来自机构调研要点：益佩生2026年1月1日起全国执行医保，覆盖人群与用药可及性明显提升。目前派格宾已参与广东联盟集采、江西牵头的干扰素省际联盟集采，两大联盟覆盖全国大部分地区。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092000000251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638746","title":"股市必读：特宝生物新发布《特宝生物：关于召开2026年第四次临时股东会的通知》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638746?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:10","pubTimestamp":1789330218,"startTime":"0","endTime":"0","summary":"公司公告汇总特宝生物：关于召开2026年第四次临时股东会的通知厦门特宝生物工程股份有限公司将于2026年9月28日召开2026年第四次临时股东会，会议采取现场投票与网络投票相结合方式，股权登记日为2026年9月21日，登记时间截至2026年9月24日16时。本次关联交易已通过董事会及独立董事专门会议审议，尚需提交股东会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667277500","title":"每周股票复盘：特宝生物（688278）将召开临时股东会审议关联交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2667277500","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667277500?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:50","pubTimestamp":1789242618,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，特宝生物报收于52.05元，较上周的56.96元下跌8.62%。本周关注点来自公司公告汇总：特宝生物将于2026年9月28日召开第四次临时股东会，审议与关联人共同投资1亿元的议案。厦门特宝生物工程股份有限公司将于2026年9月28日召开2026年第四次临时股东会，会议采取现场投票与网络投票相结合方式，股权登记日为2026年9月21日，登记时间截至2026年9月24日16时。公司董事蓝柏林先生以自有资金出资20,000万元，构成关联交易。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666781855","title":"特宝生物（688278）披露关于与关联人共同投资暨关联交易的议案，9月11日股价下跌4.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666781855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666781855?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:35","pubTimestamp":1789137318,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，特宝生物报收于52.05元，较前一交易日下跌4.51%，最新总市值为212.46亿元。该股当日开盘54.46元，最高54.46元，最低51.85元，成交额达1.61亿元，换手率为0.75%。本次会议将审议《关于与关联人共同投资暨关联交易的议案》，中小投资者将单独计票，关联股东需回避表决。网络投票通过上海证券交易所系统进行，现场会议地点位于厦门市海沧新阳工业区翁角路330号公司会议室。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665290233","title":"特宝生物（688278）披露将参加科创板2026年半年度创新药行业集体业绩说明会，9月8日股价下跌0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665290233","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665290233?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:58","pubTimestamp":1788861490,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，特宝生物报收于56.6元，较前一交易日下跌0.91%，最新总市值为231.04亿元。近日，特宝生物发布《关于参加科创板2026年半年度创新药行业集体业绩说明会的公告》。公告显示，厦门特宝生物工程股份有限公司将于2026年9月16日15:00-17:00参加由上海证券交易所主办的科创板2026年半年度创新药行业集体业绩说明会，通过上证路演中心网络互动方式与投资者就2026年半年度经营成果及财务状况进行交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06978","159992","688278","BK0239","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792755601860,"stockEarnings":[{"period":"1week","weight":-0.0576},{"period":"1month","weight":-0.1337},{"period":"3month","weight":-0.2331},{"period":"6month","weight":-0.2192},{"period":"1year","weight":-0.4092},{"period":"ytd","weight":-0.4542}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0744},{"period":"3month","weight":-0.0409},{"period":"6month","weight":-0.1034},{"period":"1year","weight":-0.0653},{"period":"ytd","weight":-0.0783}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"厦门特宝生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11842人(较上一季度增加12.09%)","perCapita":"34469股","listingDate":"2020-01-17","address":"福建省厦门市海沧区新阳工业区翁角路330号","registeredCapital":"40818万元","survey":" 厦门特宝生物工程股份有限公司的主营业务是免疫和代谢领域创新药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康。派格宾于2025年10月获批成为全球首个以慢乙肝临床治愈为治疗终点的药物，是该领域重要基石药物。","listedPrice":8.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特宝生物,688278,特宝生物股票,特宝生物股票老虎,特宝生物股票老虎国际,特宝生物行情,特宝生物股票行情,特宝生物股价,特宝生物股市,特宝生物股票价格,特宝生物股票交易,特宝生物股票购买,特宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}